IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.130
-0.030 (-1.39%)
At close: Jun 27, 2025, 4:00 PM
2.190
+0.060 (2.82%)
After-hours: Jun 27, 2025, 6:05 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $7.34 million as of June 27, 2025. Its market cap has decreased by -87.31% in one year.
Market Cap
7.34M
Enterprise Value
-142.02K
1-Year Change
-87.31%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $7.34M, a decrease of -96.09%. That is a compound annual growth rate of -56.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 7.44M | -60.09% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |